Home/Filings/4/0001145911-16-000005
4//SEC Filing

Zosano Pharma Corp 4

Accession 0001145911-16-000005

CIK 0001587221operating

Filed

Aug 21, 8:00 PM ET

Accepted

Aug 22, 7:18 PM ET

Size

8.8 KB

Accession

0001145911-16-000005

Insider Transaction Report

Form 4
Period: 2016-08-19
KELLERMAN DONALD J
VP, Clinical Dev & Med Affairs
Transactions
  • Purchase

    Series B Warrants (right to buy)

    2016-08-19$0.13/sh+15,920$1,99015,920 total
    Exercise: $1.55From: 2016-08-19Exp: 2021-08-19Common Stock (15,920 underlying)
  • Purchase

    Common Stock

    2016-08-19$1.32/sh+15,920$21,01415,920 total
  • Purchase

    Series A Warrants (right to buy)

    2016-08-19$0.13/sh+15,920$1,99015,920 total
    Exercise: $1.45From: 2016-08-19Exp: 2017-08-26Common Stock (15,920 underlying)

Issuer

Zosano Pharma Corp

CIK 0001587221

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001587221

Filing Metadata

Form type
4
Filed
Aug 21, 8:00 PM ET
Accepted
Aug 22, 7:18 PM ET
Size
8.8 KB